ALBIREO PHARMA INC's ticker is ALBO and the CUSIP is 01345P106. A total of 111 filers reported holding ALBIREO PHARMA INC in Q1 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $3,974,122 | +16.0% | 183,902 | +3.9% | 0.00% | 0.0% |
| Q3 2022 | $3,427,000 | -4.9% | 177,018 | -2.4% | 0.00% | 0.0% |
| Q2 2022 | $3,603,000 | -34.6% | 181,432 | -1.7% | 0.00% | 0.0% |
| Q1 2022 | $5,506,000 | +24.1% | 184,577 | -3.1% | 0.00% | 0.0% |
| Q4 2021 | $4,436,000 | -27.1% | 190,445 | -2.3% | 0.00% | 0.0% |
| Q3 2021 | $6,082,000 | -13.1% | 194,931 | -2.0% | 0.00% | 0.0% |
| Q2 2021 | $6,999,000 | -3.8% | 198,958 | -3.6% | 0.00% | 0.0% |
| Q1 2021 | $7,274,000 | -14.3% | 206,367 | -8.8% | 0.00% | -50.0% |
| Q4 2020 | $8,489,000 | +30.0% | 226,339 | +15.7% | 0.00% | +100.0% |
| Q3 2020 | $6,529,000 | +24.4% | 195,680 | -1.2% | 0.00% | 0.0% |
| Q2 2020 | $5,248,000 | +82.6% | 198,105 | +12.8% | 0.00% | 0.0% |
| Q1 2020 | $2,874,000 | -24.5% | 175,604 | +17.3% | 0.00% | 0.0% |
| Q4 2019 | $3,805,000 | +27.1% | 149,691 | +0.0% | 0.00% | 0.0% |
| Q3 2019 | $2,993,000 | -22.6% | 149,649 | +24.8% | 0.00% | 0.0% |
| Q2 2019 | $3,866,000 | +2.4% | 119,893 | +2.2% | 0.00% | 0.0% |
| Q1 2019 | $3,777,000 | +35.4% | 117,262 | +3.1% | 0.00% | 0.0% |
| Q4 2018 | $2,789,000 | -25.6% | 113,693 | -0.0% | 0.00% | 0.0% |
| Q3 2018 | $3,749,000 | +5.8% | 113,719 | +13.9% | 0.00% | 0.0% |
| Q2 2018 | $3,544,000 | +590.8% | 99,819 | +533.1% | 0.00% | – |
| Q1 2018 | $513,000 | +103.6% | 15,766 | +60.3% | 0.00% | – |
| Q4 2017 | $252,000 | +23.5% | 9,834 | -0.5% | 0.00% | – |
| Q2 2017 | $204,000 | – | 9,886 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 174,791 | $6,556,000 | 3.03% |
| Sio Capital Management, LLC | 354,210 | $13,286,000 | 2.72% |
| Birchview Capital, LP | 92,000 | $3,451,000 | 1.99% |
| Chicago Capital, LLC | 618,263 | $23,191,000 | 1.04% |
| Perceptive Advisors | 2,360,139 | $88,529,000 | 0.95% |
| Endurant Capital Management LP | 42,292 | $1,586,000 | 0.57% |
| Artal Group S.A. | 700,000 | $26,257,000 | 0.56% |
| Cormorant Asset Management, LP | 500,000 | $18,755,000 | 0.45% |
| Samsara BioCapital, LLC | 100,000 | $3,751,000 | 0.38% |
| RICE HALL JAMES & ASSOCIATES, LLC | 257,372 | $9,654,000 | 0.34% |